Illuminated and isolated electrosurgical apparatus

Information

  • Patent Grant
  • 12089888
  • Patent Number
    12,089,888
  • Date Filed
    Friday, April 28, 2023
    a year ago
  • Date Issued
    Tuesday, September 17, 2024
    3 months ago
Abstract
Unintended current flow or plasma discharge has been observed in known illuminated electrosurgical devices having a metallic tubular heat sink surrounding a conductive electrode and an illumination element, and having a distal outer edge that abuts against the light emitting element. An insulating, shielding or other isolating element that prevents or discourages unintended plasma formation between the distal outer edge and nearby patient tissue can reduce the potential for tissue damage to a patient or injury to a surgeon.
Description
TECHNICAL FIELD

The present application relates to illuminated electrosurgical devices.


BACKGROUND

Illuminated electrosurgical devices generally include a hand piece (handle) ergonomically adapted for ease of manipulation by a surgeon during surgery, and for positioning an energy tip of the device to deliver electrical energy to a target tissue for tissue cutting or coagulation. An electrode and electrical supply cable are generally disposed within the handle, traversing from the handle's proximal end through the handle body, and terminating in an energy discharge tip at the distal end of the device. The electrical supply cable typically is connected to an energy source, such as a radiofrequency (RF) energy generator.


The handle or other portion of the device may include an illumination element for illuminating the surgical field. Light may be conducted towards the energy discharge tip and directed onto the surgical field via an optical waveguide coupled to the handle or disposed within the handle. The electrode may be disposed within the optical waveguide, or disposed alongside the waveguide. The electrode and waveguide may be disposed within a suitable supporting structure (for example, a cylindrical metal tube), that may be slidably extendable or retractable to permit the electrosurgical device to elongate or shorten as needed to treat the surgical site.


SUMMARY

The present invention provides an improved illuminated electrosurgical device having reduced tendency to cause unintended current flow or plasma discharge and patient injury. In one embodiment, the device comprises:

    • a) a handle;
    • b) a conductive electrode supported by the handle and having a tip for cutting or cauterizing tissue;
    • c) an illumination element coupled to the handle, the illumination element comprising a light source, an optical waveguide, and a light emitting element illuminating the electrode tip;
    • d) a metallic tubular heat sink surrounding at least part of the conductive electrode and illumination element and having a distal outer edge that abuts against the light emitting element; and
    • e) an insulating, shielding or other isolating element that prevents or discourages unintended current flow or plasma formation between the distal outer edge and nearby patient tissue.


The disclosed invention addresses shortcomings in current electrosurgical devices, by preventing or discouraging unintended RF energy release and accidental injury to the patient or surgeon. The invention includes modification of a known device to insulate, isolate or shield the distal end of a metal heat sink on such device (for example, by adding electrical insulation over the distal end), thereby preventing or discouraging the unwanted release of energy.


The above summary is not intended to describe each illustrated embodiment or every implementation of the disclosed subject matter. The details of one or more embodiments of the invention are set forth in the accompanying Drawing and this Specification. Other features, objects, and advantages of the invention will be apparent from the Drawing, the Specification and the claims.





BRIEF DESCRIPTION OF THE DRAWING

The disclosed subject matter may be more completely understood from the accompanying figures, in which:



FIG. 1 is a perspective view, partially in section, of a known illuminated electrosurgical device;



FIG. 2 is an exploded view of distal components of the FIG. 1 device;



FIG. 3 is a cross-sectional view of the assembled FIG. 2 components;



FIG. 4 through FIG. 10 are sectional views of various embodiments of the invention; and



FIG. 11 is a photograph showing the unintended discharge of energy from the FIG. 1 device onto nearby tissue.





Like reference symbols in the various figures of the Drawing indicate like elements. The elements in the Drawing are not to scale.


DEFINITIONS

Unless the context indicates otherwise, the following terms shall have the following meaning and shall be applicable both to the singular and plural:


The terms “conductor”, “conductive” and “conducting” mean electrically conductive, and refer to materials that readily permit the flow of electrical current through such material. Conductive materials may in some instances be thermally conductive but are not always so. Materials such as carbon black, moisture and metals are representative conducting materials.


The term “electrosurgical device” means an electrical device designed for handheld use by a surgeon to dispense RF or other energy through the tip of an electrode into target surgical tissue, in order to cut or coagulate the tissue during a surgical procedure.


The terms “insulator”, “insulation” and “insulating” mean electrically insulating, and refer to dielectric materials that permit little, if any, flow of electrical current through such material. Insulating materials may in some instances be thermal insulators but are not always so. Materials such as glass, metal oxides, porcelain, paper, plastics, polymers and rubbers are representative insulating materials.


The terms “radiofrequency energy” or “RF” energy mean energy from the electromagnetic spectrum having a frequency between about 3 kilohertz (3 kHz) and about 300 gigahertz (300 GHz).


DETAILED DESCRIPTION

Surgical devices should not unduly impede the surgeon's view of the operating field. This is particularly troublesome in electrosurgical devices, especially those with extra features beyond energy delivery, such as added illumination, smoke evacuation, saline delivery, or other ancillary features.


In the case of an electrosurgical device which also provides added illumination (viz. light directed at the surgical field), the light desirably is emitted near the distal end of the device, where any added bulk may also directly impede the surgeon's view. Device designers have consequently sought to minimize the distal profile of such devices, and to make the associated components as small, thin and few in number as possible.



FIG. 1 shows a known electrosurgical device 100 supplied by Invuity, Inc. as the PhotonBlade™ electrosurgical device. Device 100 includes a handle 102 in which is mounted a tubular metal heat sink 104 that can be slidably extended from or pushed into handle 102 and fixed in place with a collet or other locking mechanism (not shown in FIG. 1). Doing so permits a surgeon to vary the length of device 100 as may be needed for particular surgical procedures.


Conductive electrode 106 is partially housed within heat sink 104, and includes a distally projecting RF energy discharge tip 108 intended to emit RF energy to cut or cauterize human or animal tissue. Electrode 106 also includes a conductive leg portion 110 extending towards handle 102, and intended to be connected (e.g., via an electrical connector, solder or other suitable connection not shown in FIG. 1) with a conductive cable (also not shown in FIG. 1) that passes through handle 102 and supplies RF energy to electrode 106. Optionally, the electrode 106 may include an enamel insulative coating such as those disclosed in U.S. Pat. No. 7,736,361 B2. Leg portion 110 resides in a slot 112 formed in optical waveguide 116 and passes through a notch 118 in light source 120, shown here as a circuit board housing a light emitting diode (LED) 122. Light from LED 122 is captured by parabolic light collector 124 and transmitted through waveguide 116 towards translucent light emitting element 126. A layer of cladding 128 surrounds optical waveguide 116 and is said to provide desired optical properties to optical waveguide 116. The front or distal end of heat sink 104 abuts against the rear or proximal face of light emitting element 126. During use of device 100, light is emitted from lenslets 130 on the front face of element 126, as well as from outer edge 132 of element 126.



FIG. 2 shows an exploded view of distal components of the FIG. 1 device. Optical waveguide 116, collector 124 and light emitting element 126 are respectively formed from half guides 116a and 116b, half collectors 124a and 124b, and half elements 126a and 126b. Slot 114 and cladding 122 have the shapes shown in FIG. 2. As supplied in device 100, tubular metal heat sink 104 has a thin outer layer of insulation (not labeled in FIG. 2). Cut end 134 of heat sink 104 is however not insulated, and cut end 134, and especially its outer edge 136, have a high electrical potential and can promote unintended RF discharge.



FIG. 3 is a cross-sectional view of the assembled FIG. 2 components. Cut end 134 abuts against the rear face of light emitting element 126. Arrow P indicates a point from which unintended RF energy may be emitted from device 100 toward tissue beneath device 100, especially when high power levels (e.g., power levels of at least 10 watts, at least 20 watts, at least 30 watts, at least 40 watts or at least 50 watts) are employed. When such emission occurs, current can flow or plasma can form between cut end 134 or outer edge 136 and nearby tissue, causing tissue burning at other than the intended surgical site, while meanwhile depowering electrode 106 and preventing tip 108 from cutting or cauterizing target tissue.



FIG. 11 is a photograph showing such unintended current flow or plasma formation, in a simulated electrosurgery performed as described in Example 1. Burn marks A and B were caused by two prior unintended plasma bursts, and an unintended plasma formed under the distal end of heat sink 104.



FIG. 4 shows one solution to the unintended current flow or plasma generation problem discussed above. Light emitting element 426 has a larger outside diameter than heat sink 104, and includes a rim portion 428 that extends proximally along at least a portion of heat sink 104 (e.g., at least 1 mm, at least 2 mm, at least 3 mm, at least 4 mm or at least 5 mm, and up to 10 mm, up to 9 mm or up to 8 mm) and has sufficient thickness (e.g., at least 0.2 mm, at least 0.3 mm, at least 0.4 mm or at least 0.5 mm, and up to 2 mm, up to 1.8 mm, up to 1.6 mm or up to 1.5 mm) so that cut end 134 and edge 136 are buried within and insulated by rim portion 428. This improves the electrical isolation of cut end 134, and discourages or prevents unintended current flow or plasma generation. The thickness and length of rim portion 428 (and the thickness, shape or composition of the other insulating, shielding or other isolating measures discussed below) may be empirically determined, for example by repeating the chicken tissue test discussed above and in Example 1, or by measuring breakdown voltage using the Hi-Pot test discussed in Example 2. In certain embodiments, the added insulating, shielding or other isolating measure is sufficient to prevent unintended current flow or plasma generation when using the Example 1 experimental setup and an operating power of 10 watts, 20 watts, 30 watts, 40 watts or 50 watts, while contacting the chicken tissue with the light emitting element, or while laying the heat sink atop the tissue. In certain other embodiments, the added insulating, shielding or other isolating measure is sufficient to increase the breakdown voltage using the Example 2 Hi-Pot test and the metal heat sink alone without the handle and tip, to at least 2 KV RMS@20 seconds, at least 3 KV RMS@20 seconds or at least 4 KV RMS@20 seconds.



FIG. 5 shows another solution to the unintended current flow or plasma generation problem discussed above. A bead 502 of a suitable curable or hardenable insulating material (e.g., a room temperature vulcanizing silicone resin, a curable thermoset epoxy or other preferably thermosetting insulating material, a hardenable inorganic liquid such as waterglass or a hardenable inorganic paste such as plaster of Paris) is placed over outer edge 132 of light emitting element 126 and over outer edge 136 and at least a portion of the distal end of heat sink 104, and then cured or hardened. In an embodiment, a bead of the insulating material is applied to light emitting element 126 before heat sink 104 is abutted against element 126, followed by pushing heat sink 104 and element 126 together, so that cut end 134 will contact and be embedded in bead 502. If a translucent or transparent insulating material is employed for bead 502, or if the width of bead 502 is such that a portion of outer edge 132 of element 126 remains uncovered, then light may continue to be emitted from outer edge 132 during surgery. This may be desirable in some instances, but may be undesirable in others. For example, if an opaque insulating material is employed for bead 502, light may no longer be emitted from outer edge 132, and glare may be reduced or eliminated during surgery. If desired, the axial length of element 126 may be increased so that outer edge 132 may be made wider, thereby permitting bead 502 to be made wider as well while preserving or largely preserving the original width of outer edge 132. In any event, the thickness, width and composition of bead 502 may be empirically determined using the Example 1 or Example 2 procedures discussed above in connection with the FIG. 4 embodiment. Bead 502 may for example have a thickness of at least 0.1 mm, at least 0.2 mm, at least 0.3 mm, at least 0.4 mm or at least 0.5 mm, and up to 2 mm, up to 1.5 mm or up to 1 mm. Bead 502 may for example have a width of at least 1 mm, at least 2 mm, at least 3 mm, at least 4 mm or at least 5 mm, and up to 10 mm, up to 9 mm or up to 8 mm.



FIG. 6 shows another solution to the unintended current flow or plasma generation problem discussed above. An insulating coating 602 (preferably a coating that is thicker, less conductive, or both thicker and less conductive than the insulative layer currently employed on heat sink 104) is coated onto cut end 134 and over at least a portion of heat sink 104. Coating 602 may for example be a paint, a vapor-deposited polymeric film, a cured or hardened layer of an organic or inorganic material, or a layer of glass. In a preferred embodiment, coating 602 also covers at least a portion of the inner sidewall of heat sink 104, and may for example extend along heat sink 104 past the proximal end of leg 110. The thickness, width, composition and configuration of coating 602 may be empirically determined using the Example 1 or Example 2 procedures discussed above in connection with the FIG. 4 embodiment. Coating 602 may for example have a thickness of at least 0.05 mm, at least 01 mm, at least 0.2 mm, at least 0.3 mm, at least 0.4 mm or at least 0.5 mm, and up to 2 mm, up to 1.5 mm or up to 1 mm. Coating 602 may for example extend proximally away from cut edge 134 along the inner or outer sidewalls of heat sink 104 for a distance of at least 1 mm, at least 2 mm, at least 3 mm, at least 4 mm or at least 5 mm, and up to the entire length of heat sink 104, past the proximal end of leg 110, or for at least the distal 20 mm, 10 mm or 8 mm of heat sink 104.



FIG. 7 shows another solution to the unintended current flow or plasma generation problem discussed above. A length of rubber or plastic tubing 702 is placed over cut end 134 and over at least a portion of outer edge 132 of element 126 and over at least a portion of the distal end of heat sink 104, to form an insulating sleeve or collar. Tubing 702 may for example be an elastomeric tubing material such as surgical or other tubing made from natural rubber, fluoroelastomer, latex, silicone or polyvinyl chloride (PVC). Tubing 702 may also be a heat-shrinkable tubing such as a polyolefin, neoprene or fluoropolymer material. The thickness, width and composition of tubing 702 may be empirically determined using the Example 1 or Example 2 procedures discussed above in connection with the FIG. 4 embodiment. Tubing 702 may for example have a thickness of at least 0.1 mm, at least 0.2 mm, at least 0.3 mm, at least 0.4 mm or at least 0.5 mm, and up to 2 mm, up to 1.5 mm or up to 1 mm. Tubing 702 may for example have a width of at least 2 mm, at least 3 mm, at least 4 mm or at least 5 mm, and up to 10 mm, up to 9 mm or up to 8 mm.



FIG. 8 shows another solution to the unintended current flow or plasma generation problem discussed above. A least one and preferably two or more turns of adhesive tape (e.g., PVC electrical tape) 802 are wrapped around at least a portion of outer edge 132 of element 126, over cut end 134 and over at least a portion of the distal end of heat sink 104. A spiral wrap pattern or a wrap pattern in which the ends of the tape are aligned with and overlap one another may be used. The thickness, width, composition and number of turns of tape 802 may be empirically determined using the Example 1 or Example 2 procedures discussed above in connection with the FIG. 4 embodiment. Tape 802 may for example have a thickness of at least 0.1 mm, at least 0.2 mm or at least 0.3 mm, and up to 2 mm, up to 1.5 mm or up to 1 mm. Tape 702 may for example have a width of at least 2 mm, at least 3 mm, at least 4 mm or at least 5 mm, and up to 20 mm, up to 16 mm or up to 10 mm.



FIG. 9 shows another solution to the unintended current flow or plasma generation problem discussed above. The thickness, composition or both thickness and composition of cladding 928 are changed to increase the breakdown voltage exhibited by heat sink 104. The extent to which such changes are made may be empirically determined using the Example 1 or Example 2 procedures discussed above in connection with the FIG. 4 embodiment. Cladding 928 may for example have a thickness of at least 0.1 mm, at least 0.2 mm or at least 0.3 mm, and up to 2 mm, up to 1.5 mm or up to 1 mm, and may be made from a variety of suitable dielectric materials including ceramics, glass, paper, plastics and rubber.



FIG. 10 shows another solution to the unintended current flow or plasma generation problem discussed above. Some or all of the portions of electrode 106 that contact light emitting element 126 or that extend through heat sink 104 (and especially those parts of electrode 106 such as leg 110 which are positioned near the inner wall of heat sink 104) can be coated with a layer 1040 of a suitable insulating material to increase the breakdown voltage exhibited by heat sink 104. The thickness, arrangement and composition of such a coating may be empirically determined using the Example 1 or Example 2 procedures discussed above in connection with the FIG. 4 embodiment. Coating 1040 may for example have a thickness of at least 0.1 mm, at least 0.2 mm or at least 0.3 mm, and up to 2 mm, up to 1.5 mm or up to 1 mm, and may be made from a variety of suitable dielectric materials including ceramics, glass, paper, plastics and rubber.


In an additional embodiment shown in FIG. 9, a continuous or discontinuous (e.g., screened) conductive layer 930 may be placed between cladding 928 and heat shield 104, and connected to an earth ground. Doing so can reduce the voltage potential at cut end 134 and along the length of heat shield 104, and discourage unintended external current flow or plasma generation. The additional conductive layer 930 may if desired be included as a part of cladding 928 (for example, as an outer layer) or may be included as a part of heat sink 104 (for example, as an inner layer separated from the inner metallic wall of heat sink 104 by a suitable insulating layer on such inner wall. When such an additional conductive layer 930 is employed, it may also be necessary or desirable to employ additional insulating measures on portions of the device inside the additional conductive layer 930 (for example, by making changes to cladding 928 as discussed in connection with FIG. 9, or by coating portions of electrode 106 as discussed in connection with FIG. 10), so as to avoid undesirable internal current leakage or internal current flow or plasma generation during use.


In an additional embodiment, not shown in the Drawing, electrode 106 and one or more of optical waveguide 116, light source 120, light collector 124 and light emitting element 126 can be redesigned so that those portions of electrode 106 that lie inside heat sink 104 are further from the inner wall of heat 110 than is presently the case in device 100. In one embodiment, electrode 106 may be made narrower as it passes through light emitting element 126 and optical waveguide 116. In the same or another embodiment, leg 110 is rerouted so that it runs through the center of device 100 rather than near the inner wall of heat sink 104, and light source 120 and light collector 124 are modified so that LED 122 is not in the way of leg 110 and optical waveguide 116 is edge-lit rather than centrally illuminated.


In an additional embodiment, not shown in the Drawing, all or at least a distal portion of heat sink 104 is made from an insulating material rather than from metal. Exemplary such materials include ceramics, glass and plastics. The thickness, composition and configuration of such an insulating material may be empirically determined using the Example 1 or Example 2 procedures discussed above in connection with the FIG. 4 embodiment.


The various insulation materials mentioned above may be interchanged for one another or replaced or combined with a variety of other insulation materials. Preferred insulation materials include acrylics, acrylates, acrylonitrile-butadiene-styrene (ABS) copolymers, cyanoacrylate adhesives, epoxies, fluorinated ethylene propylene (FEP) elastomers, polycarbonates, polyimides, polytetrafluoroethylene (PTFE) plastics, natural and synthetic rubbers, non-conductive adhesives, RTV and other silicone rubbers, polyurethanes, inorganic dielectrics, glass, ceramics, porcelain, and other insulating materials that will be familiar to persons having ordinary skill in the art.


EXAMPLES
Example 1
Simulated Electrosurgery

Simulated electrosurgery was performed using a skinless chicken breast, a Valleylab Force FX™ isolated output electrosurgical generator set to 50 watt, high coagulation output, and device 100. The device had previously been used in an electrosurgical procedure. The results are shown in FIG. 11. Burn marks A and B were caused by two prior unintended current or plasma bursts when device 100 was held at an angle and light emitting element 126 was allowed to contact the tissue. An unintended plasma was visible under the distal end of heat sink 104. Meanwhile electrode 106 is depowered and energy discharge tip 108 cannot be used for cutting or cauterizing target tissue. The tendency for unintended plasma generation to occur increased significantly whenever device 100 was held at an acute angle with respect to the chicken tissue, and increased as the distance from end 134 to the tissue diminished. At a sufficiently small distance or upon contact of light emitting element 126 against the tissue, an unintended plasma discharge commenced. Unintended plasma generation also occurred whenever heat sink 104 was laid atop the tissue. The plasma continued until device 100 was pulled or tipped away from the tissue, and meanwhile the tissue became charred and the odor of cooked chicken emanated from the burn sites. Upon removal from the tissue, a dark discolored region was visible near the portion of edge 134 that had been closest to the tissue, and the corresponding bluish insulation layer on heat sink 104 appeared to have been burned away.


These results suggest that in tight anatomical spaces where contact between the edge of the metal heat sink tube and tissue cannot be avoided, tissue damage will likely occur due to RF energy release between the distal edge of the metal tube and the surgical target tissue, particularly when the device is used for coagulation.


Example 2
IEC Hi-Pot Test

International Standard IEC 60601-2-2 (the IEC Hi-Pot Test) may be used to test dielectric strength and leakage current for both monopolar and bipolar high frequency electrosurgical devices, and their individual components. An Invuity PhotonBlade electrosurgical device that had previously been used in a surgical procedure was disassembled and its components subjected to the IEC Hi-Pot Test to determine breakdown voltages and evaluate potential energy leakage for various components and subassemblies. The Valleylab Force FX™ electrosurgical generator used in Example 1 was employed for the IEC test. The Force FX generator has a maximum voltage output of 3.89 KV RMS. Each of the handle 102 only (without the heat sink 110 and the components it contains); the handle 102 with the heat sink 110 and the components it contains (but without buttons); the handle 102 and its cable (but without buttons and without heat sink 110 and the components it contains); and the heat sink 110 and some of components it contains (but without handle 102 and the exposed portion of electrode 106) were evaluated for potential energy leakage. The test results are shown below in Table 1.










TABLE 1





Test Setup
Failure Voltage







Handle Only (no Heat Sink)
3.89 KV RMS @ 20 seconds


Handle and Heat Sink (no Buttons)
 2.7 KV RMS @ 20 seconds


Handle and Cable (no
3.01 KV RMS @ 20 seconds


Buttons and no Heat Sink)


Heat Sink Only (no Handle or Tip)
 1.6 KV RMS @ 20 seconds









The results in Table 1 show that each of the tested components may have voltage breakdown issues, with the heat sink representing the weakest tested link.


Various embodiments of systems, devices, and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the claimed invention. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, configurations and locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the claimed inventions. For example, persons of ordinary skill in the relevant art will recognize that the subject matter hereof may comprise fewer features than illustrated in any individual embodiment described above. The embodiments described herein are not meant to be an exhaustive presentation of the ways in which the various features of the subject matter hereof may be combined. Accordingly, the embodiments are not mutually exclusive combinations of features; rather, the various embodiments can comprise a combination of different individual features selected from different individual embodiments, as understood by persons of ordinary skill in the art. Moreover, elements described with respect to one embodiment can be implemented in other embodiments even when not described in such embodiments unless otherwise noted.


Although a dependent claim may refer in the claims to a specific combination with one or more other claims, other embodiments can also include a combination of the dependent claim with the subject matter of each other dependent claim or a combination of one or more features with other dependent or independent claims. Such combinations are proposed herein unless it is stated that a specific combination is not intended.


For purposes of interpreting the claims, it is expressly intended that the provisions of 35 U.S.C. § 112(f) are not to be invoked unless the specific terms “means for” or “step for” are recited in a claim.

Claims
  • 1. An electrosurgical device comprising: a) a handle;b) a conductive electrode supported by the handle and having a tip for cutting or cauterizing tissue;c) an illumination element coupled to the handle, the illumination element comprising a light source, an optical waveguide, and a light emitting element illuminating the electrode tip, the light emitting element having an outer edge;d) a metallic tubular heat sink surrounding at least part of the conductive electrode and illumination element and having an outer sidewall and a distal outer edge that abuts against the light emitting element; ande) an insulating, shielding or other isolating element that prevents or discourages unintended current flow or plasma formation between the distal outer edge and nearby patient tissue,wherein:the insulating, shielding or other isolating element covers the distal outer edge of the heat sink and at least a portion of the outer sidewall;the insulating, shielding or other isolating element covers at least a portion of the outer edge of the light emitting element; andthe insulating, shielding or other isolating element comprises an opaque material configured to reduce or eliminate glare from the outer edge of the light emitting element.
  • 2. The device of claim 1, wherein the insulating, shielding or other isolating element covers the entire outer edge of the light emitting element.
  • 3. The device of claim 1, wherein the heat sink has an inner sidewall and the insulating, shielding or other isolating element also covers at least a portion of the inner sidewall.
  • 4. The device of claim 3, wherein the electrode has a proximal end and the insulating, shielding or other isolating element extends along the inner sidewall past such proximal end.
  • 5. The device of claim 1, wherein the heat sink has a distal end that is embedded within and insulated by the rim portion insulating, shielding or other isolating element.
  • 6. The device of claim 1, wherein the insulating, shielding or other isolating element comprises a paint, vapor-deposited polymeric film, cured or hardened layer of an organic or inorganic material, or layer of glass.
  • 7. The device of claim 1, wherein the insulating, shielding or other isolating element comprises a length of rubber or plastic tubing that forms an insulating sleeve or collar.
  • 8. The device of claim 7, wherein the tubing comprises an elastomeric natural rubber, fluoroelastomer, latex, silicone or polyvinyl chloride.
  • 9. The device of claim 7, wherein the tubing comprises heat-shrinkable tubing.
  • 10. The device of claim 1, wherein the insulating, shielding or other isolating element also comprises cladding that surrounds the optical waveguide and whose thickness, composition or both thickness and composition increase the breakdown voltage exhibited by the heat sink.
  • 11. The device of claim 10, comprising a continuous or discontinuous conductive layer between the cladding and the heat sink, and connected to an earth ground.
  • 12. The device of claim 1, wherein portions of the electrode contact the light emitting element and extend through the heat sink and are coated with insulating material layer that increases the breakdown voltage exhibited by heat sink.
  • 13. The device of claim 1, wherein all or at least a distal portion of the heat sink is made from an insulating material rather than from metal.
  • 14. The device of claim 1, wherein the insulating, shielding or other isolating element comprises an insulation material selected from acrylics, acrylates, acrylonitrile-butadiene-styrene (ABS) copolymers, cyanoacrylate adhesives, epoxies, fluorinated ethylene propylene (FEP) elastomers, polycarbonates, polyimides, polytetrafluoroethylene (PTFE) plastics, natural and synthetic rubbers, non-conductive adhesives, RTV and other silicone rubbers, polyurethanes, inorganic dielectrics, glass, ceramics or porcelain.
  • 15. The device of claim 1, wherein the insulating, shielding or other isolating element has a thickness of at least about 0.2 mm.
  • 16. The device of claim 1, wherein the insulating, shielding or other isolating element has a thickness of at least about 0.4 mm.
  • 17. The device of claim 1, wherein the device does not release RF energy from a site other than the electrode tip.
  • 18. The device of claim 1, wherein the insulating, shielding or other isolating element prevents unintended current flow or plasma generation when using an operating power of 30 watts while contacting chicken tissue with the light emitting element, or while laying the heat sink atop such tissue.
  • 19. The device of claim 1, wherein the insulating, shielding or other isolating element prevents unintended current flow or plasma generation when using an operating power of 50 watts while contacting chicken tissue with the light emitting element, or while laying the heat sink atop such tissue.
  • 20. The device of claim 1, wherein the insulating, shielding or other isolating element increases the breakdown voltage of the heat sink, measured without the handle and tip, to at least 2 KV RMS @, 20 seconds.
  • 21. The device of claim 1, wherein the insulating, shielding or other isolating element increases the breakdown voltage of the heat sink, measured without the handle and tip, to at least 3 KV RMS @ 20 seconds.
  • 22. The device of claim 1, wherein the insulating, shielding or other isolating element increases the breakdown voltage of the heat sink, measured without the handle and tip, to at least 4 KV RMS @ 20 seconds.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 17/028,192, filed Sep. 22, 2020 (now U.S. Pat. No. 11,672,591 B2), which is a divisional of U.S. application Ser. No. 16/232,705, filed Dec. 26, 2018 (now U.S. Pat. No. 10,806,504 B2), which is a continuation of U.S. application Ser. No. 15/887,503, filed Feb. 2, 2018 (now U.S. Pat. No. 10,194,975 B1), which claims priority to U.S. Provisional Application No. 62/531,188, filed Jul. 11, 2017, the entire disclosures of which are incorporated herein by reference.

US Referenced Citations (284)
Number Name Date Kind
2888928 Seiger Jun 1959 A
3677262 Henry Jul 1972 A
4207897 Lloyd et al. Jun 1980 A
4244371 Farin Jan 1981 A
4248224 Mitchiner Feb 1981 A
4275734 van Gerven Jun 1981 A
4276874 Wolvek et al. Jul 1981 A
4321931 Hon Mar 1982 A
4342218 Fox Aug 1982 A
4377168 Rzasa et al. Mar 1983 A
4519389 Gudkin et al. May 1985 A
4562838 Walker Jan 1986 A
4597030 Brody et al. Jun 1986 A
4598698 Siegmund Jul 1986 A
4601290 Effron et al. Jul 1986 A
4664110 Schanzlin May 1987 A
4688569 Rabinowitz Aug 1987 A
4736749 Lundback Apr 1988 A
4779611 Grooters et al. Oct 1988 A
4802475 Weshahy et al. Feb 1989 A
4815470 Curtis et al. Mar 1989 A
4872346 Kelly-Fry et al. Oct 1989 A
4916922 Mullens Apr 1990 A
4917095 Fry et al. Apr 1990 A
4931047 Broadwin et al. Jun 1990 A
4936281 Stasz Jun 1990 A
4946460 Merry et al. Aug 1990 A
5013312 Parins et al. May 1991 A
5029574 Shimamura et al. Jul 1991 A
5044165 Linner et al. Sep 1991 A
5078713 Varney Jan 1992 A
5080102 Dory Jan 1992 A
5080660 Buelina Jan 1992 A
5100388 Behl et al. Mar 1992 A
5108390 Potocky et al. Apr 1992 A
5147355 Freidman et al. Sep 1992 A
5178133 Pena Jan 1993 A
5207674 Hamilton May 1993 A
5217860 Fahy et al. Jun 1993 A
5221279 Cook et al. Jun 1993 A
5222501 Ideker et al. Jun 1993 A
5224943 Goddard Jul 1993 A
5228923 Hed Jul 1993 A
5231995 Desai Aug 1993 A
5232516 Hed Aug 1993 A
5250047 Rydell Oct 1993 A
5254116 Baust et al. Oct 1993 A
5263493 Avitall Nov 1993 A
5269291 Carter Dec 1993 A
5275595 Dobak, III Jan 1994 A
5277201 Stern Jan 1994 A
5281213 Milder et al. Jan 1994 A
5281215 Milder Jan 1994 A
5295484 Marcus et al. Mar 1994 A
5309896 Moll et al. May 1994 A
5316000 Chapelon et al. May 1994 A
5317878 Bradshaw et al. Jun 1994 A
5318525 West et al. Jun 1994 A
5322520 Milder Jun 1994 A
5323781 Ideker et al. Jun 1994 A
5324255 Passafaro et al. Jun 1994 A
5324284 Imran Jun 1994 A
5324286 Fowle Jun 1994 A
5334181 Rubinsky et al. Aug 1994 A
5334193 Nardella et al. Aug 1994 A
5348554 Imran et al. Sep 1994 A
5353783 Nakao et al. Oct 1994 A
5354258 Dory Oct 1994 A
5361752 Moll et al. Nov 1994 A
5385148 Lesh et al. Jan 1995 A
5396887 Imran Mar 1995 A
5397304 Truckai Mar 1995 A
5400770 Nakao et al. Mar 1995 A
5400783 Pomeranz et al. Mar 1995 A
5403309 Coleman et al. Apr 1995 A
5403311 Abele et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5409483 Campbell et al. Apr 1995 A
5423807 Milder Jun 1995 A
5423811 Imran et al. Jun 1995 A
5427119 Swartz et al. Jun 1995 A
5431649 Mulier et al. Jul 1995 A
5433708 Nichols et al. Jul 1995 A
5435308 Gallup et al. Jul 1995 A
5437651 Todd et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5542196 Hirsch et al. Aug 1996 A
5573424 Poppe Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575788 Baker et al. Nov 1996 A
5575810 Swanson et al. Nov 1996 A
5578007 Imran Nov 1996 A
5582609 Swanson et al. Dec 1996 A
5588432 Crowley Dec 1996 A
5590657 Cain et al. Jan 1997 A
5595183 Swanson et al. Jan 1997 A
5607462 Imran Mar 1997 A
5617854 Munsif Apr 1997 A
5630837 Crowley May 1997 A
5637090 McGee et al. Jun 1997 A
5643197 Brucker et al. Jul 1997 A
5656029 Imran et al. Aug 1997 A
5658278 Imran et al. Aug 1997 A
5671747 Connor Sep 1997 A
5673695 McGee et al. Oct 1997 A
5676662 Fleischhacker et al. Oct 1997 A
5676692 Sanghvi et al. Oct 1997 A
5676693 Lafontaine Oct 1997 A
5678550 Bassen et al. Oct 1997 A
5680860 Imran Oct 1997 A
5681278 Igo et al. Oct 1997 A
5681308 Edwards et al. Oct 1997 A
5687723 Avitall Nov 1997 A
5687737 Branham et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5690611 Swartz et al. Nov 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697925 Taylor Dec 1997 A
5697927 Imran et al. Dec 1997 A
5817091 Nardella et al. Oct 1998 A
5871523 Fleischman et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873845 Cline et al. Feb 1999 A
5876399 Chia et al. Mar 1999 A
5879295 Li et al. Mar 1999 A
5879296 Ockuly et al. Mar 1999 A
5881732 Sung et al. Mar 1999 A
5882346 Pomeranz et al. Mar 1999 A
5885278 Fleischman Mar 1999 A
5893848 Negus et al. Apr 1999 A
5895417 Pomeranz et al. Apr 1999 A
5897553 Mulier Apr 1999 A
5897554 Chia et al. Apr 1999 A
5899898 Arless et al. May 1999 A
5899899 Arless et al. May 1999 A
5902289 Swartz et al. May 1999 A
5904711 Flom et al. May 1999 A
5906580 Kline-Schoder et al. May 1999 A
5906587 Zimmon May 1999 A
5906606 Chee et al. May 1999 A
5908029 Knudson et al. Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
5916214 Cosio et al. Jun 1999 A
5921924 Avitall Jul 1999 A
5921982 Lesh et al. Jul 1999 A
5927284 Borst et al. Jul 1999 A
5928191 Houser et al. Jul 1999 A
5931810 Grabek Aug 1999 A
5931848 Saadat Aug 1999 A
5954661 Greenspon et al. Sep 1999 A
5971980 Sherman Oct 1999 A
6042556 Beach et al. Mar 2000 A
6063081 Mulier May 2000 A
6071279 Whayne et al. Jun 2000 A
6088894 Oakley Jul 2000 A
6096037 Mulier Aug 2000 A
6113592 Taylor Sep 2000 A
6117101 Diederich et al. Sep 2000 A
6120496 Whayne et al. Sep 2000 A
6142994 Swanson et al. Nov 2000 A
6293943 Panescu et al. Sep 2001 B1
6302880 Schaer Oct 2001 B1
6312383 Lizzi et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6364876 Erb et al. Apr 2002 B1
6385472 Hall et al. May 2002 B1
6398792 O'Connor Jun 2002 B1
6409722 Hoey Jun 2002 B1
6419648 Vitek et al. Jul 2002 B1
6464700 Koblish et al. Oct 2002 B1
6471698 Edwards et al. Oct 2002 B1
6488678 Sherman Dec 2002 B2
6504985 Parker et al. Jan 2003 B2
6528954 Lys et al. Mar 2003 B1
6550926 Berger Apr 2003 B2
6610057 Ellman et al. Aug 2003 B1
6702810 McClurken Mar 2004 B2
6786906 Cobb Sep 2004 B1
6949098 Mulier Jul 2005 B2
7083601 Cosmescu Aug 2006 B1
7115139 McClurken Oct 2006 B2
7942872 Ein-Gal May 2011 B2
8105323 Buysse et al. Jan 2012 B2
8287534 Dethier et al. Oct 2012 B2
8506565 DeCarlo Aug 2013 B2
8690872 Jayaraj Apr 2014 B2
8882756 Greeley et al. Nov 2014 B2
8882767 Greep et al. Nov 2014 B2
8882768 Greep et al. Nov 2014 B2
9237922 Bromley Jan 2016 B2
9259260 Greep et al. Feb 2016 B2
9289261 Shvetsov et al. Mar 2016 B2
9375253 Greep et al. Jun 2016 B2
9375282 Nau, Jr. Jun 2016 B2
D761962 Fleenor Jul 2016 S
9851060 Vinod Dec 2017 B2
10194975 Hubelbank Feb 2019 B1
10806504 Hubelbank Oct 2020 B2
11672591 Hubelbank Jun 2023 B2
20020049483 Knowlton Apr 2002 A1
20020058938 Cosmescu et al. May 2002 A1
20020062131 Gallo, Sr. May 2002 A1
20020107517 Witt et al. Aug 2002 A1
20030014050 Sharkey et al. Jan 2003 A1
20030032954 Carranza et al. Feb 2003 A1
20030045872 Jacobs Mar 2003 A1
20030073993 Ciarrocca Apr 2003 A1
20030144656 Ocel Jul 2003 A1
20030191462 Jacobs Oct 2003 A1
20030204185 Sherman et al. Oct 2003 A1
20030216724 Jahns Nov 2003 A1
20040015106 Coleman Jan 2004 A1
20040024395 Ellman et al. Feb 2004 A1
20040030328 Eggers et al. Feb 2004 A1
20040044340 Francischelli Mar 2004 A1
20040049179 Francischelli Mar 2004 A1
20040078069 Francischelli Apr 2004 A1
20040082948 Stewart et al. Apr 2004 A1
20040087940 Jahns May 2004 A1
20040092926 Hoey May 2004 A1
20040138621 Jahns Jul 2004 A1
20040138656 Francischelli Jul 2004 A1
20040143260 Francischel Jul 2004 A1
20040162552 McClurken Aug 2004 A1
20040186465 Francischelli Sep 2004 A1
20040215183 Hoey Oct 2004 A1
20040220560 Briscoe Nov 2004 A1
20040236322 Mulier Nov 2004 A1
20040267326 Ocel Dec 2004 A1
20050010095 Stewart et al. Jan 2005 A1
20050090816 McClurken Apr 2005 A1
20050143729 Francischelli Jun 2005 A1
20050165392 Francischelli Jul 2005 A1
20050209564 Bonner Sep 2005 A1
20050267454 Hissong Dec 2005 A1
20060009756 Francischelli Jan 2006 A1
20060009759 Christian Jan 2006 A1
20060041254 Francischelli et al. Feb 2006 A1
20060064085 Schechter et al. Mar 2006 A1
20060116675 McClurken Jun 2006 A1
20060149225 McClurken Jul 2006 A1
20070043397 Ocel et al. Feb 2007 A1
20070049920 Greeley et al. Mar 2007 A1
20070049927 Saltzman Mar 2007 A1
20070093808 Mulier et al. Apr 2007 A1
20070118114 Miller et al. May 2007 A1
20070208226 Grey et al. Sep 2007 A1
20070208332 Mulier et al. Sep 2007 A1
20080004656 Livneh Jan 2008 A1
20080015563 Hoey et al. Jan 2008 A1
20080058587 O'Brien et al. Mar 2008 A1
20080071270 Desinger et al. Mar 2008 A1
20080207208 Schutz Aug 2008 A1
20090054890 Decarlo Feb 2009 A1
20090264879 Greeley et al. Oct 2009 A1
20090306655 Stangenes Dec 2009 A1
20100100095 Greeley et al. Apr 2010 A1
20100145333 Dethier Jun 2010 A1
20110060332 Cheng Mar 2011 A1
20110118735 Abou-Marie May 2011 A1
20110178515 Bloom et al. Jul 2011 A1
20110190768 Shvetsov Aug 2011 A1
20110196367 Gallo Aug 2011 A1
20110295249 Bloom et al. Dec 2011 A1
20110319889 Conley et al. Dec 2011 A1
20120004657 Conley et al. Jan 2012 A1
20120101496 McClurken et al. Apr 2012 A1
20120116397 Rencher et al. May 2012 A1
20120151165 Conley et al. Jun 2012 A1
20120191084 Davison et al. Jul 2012 A1
20120253343 McClurken et al. Oct 2012 A1
20120265184 Sliwa et al. Oct 2012 A1
20120283718 Cosmescu Nov 2012 A1
20120283728 Cosmescu Nov 2012 A1
20130267786 Vayser et al. Oct 2013 A1
20140221763 Vayser et al. Aug 2014 A1
20140276763 Greep et al. Sep 2014 A1
20160045247 Heim et al. Feb 2016 A1
20160157920 Vayser Jun 2016 A1
20160278874 Fleenor Sep 2016 A1
20170071667 Leung Mar 2017 A1
20180078301 Vayser et al. Mar 2018 A1
Foreign Referenced Citations (11)
Number Date Country
104161584 Aug 2017 CN
107374720 Nov 2017 CN
304557543 Mar 2018 CN
WO 9510981 Apr 1995 WO
WO 2011127902 Oct 2011 WO
WO 2012118746 Sep 2012 WO
WO 2014036118 Mar 2014 WO
WO 2014165551 Oct 2014 WO
WO 2015085108 Jun 2015 WO
WO 2016196562 Dec 2016 WO
WO 2018080963 May 2018 WO
Non-Patent Literature Citations (18)
Entry
U.S. Appl. No. 15/863,049, filed Jan. 5, 2018, First named inventor: Roger Greeley.
U.S. Appl. No. 62/543,497, filed Aug. 10, 2017, First named inventor: David Hubelbank.
U.S. Appl. No. 62/395,529, filed Sep. 16, 2016. Inventor: Alex Vayser. Title: “Methods and Apparatus for Electrosurgical Illumination”. Applicant: Invuity, Inc.
Letter from Department of Health & Human Services to Invuity, Inc., pp. 1-7 (Sep. 15, 2016).
Bennett, et al., “Assessment of Penetrating Thermal Tissue Damage/Spread Associated with PhotonBlade, Valleylab Pencil, Valleylab, EDGE, Coated Pencil, PlasmaBlade 3.0S and PlasmaBlade 4.0 for Intraoperative Tissue Dissection using the Fresh Extirpated Porcine Muscle Model” (2017), https://www.spiedigitallibrary.org/conferenceproceedings-of-spie/10066/1/Assessment-of-penetrating-thermal-tissue-damage-spread-associate-with-PhotonBlade/10.1117/12.2252111.short?SSO=1.
Class 2 Device Recall Invuity Photon Blade, Jun. 12, 2017, 1 page, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=156761.
IEC 60601-2-2 CORR 1—Medical Electrical Equipment—Part 2-2: Additional information in instructions for use Fifth Edition, 1 page (2009).
IEC 60601-2-2—Medical Electrical Equipment—Part 2-2: Particular requirements for the basic safety and essential performance of high frequency surgical equipment and high frequency surgical accessories—Edition 6.0, 190 pp (Mar. 2017).
Invulty Press Release, Sep. 25, 2017, “Invuity Announces Full Commercial Launch of Photonblade”, 1 page, http://investors.invuity.com/phoenix.zhtml?c=253978&p=irol-NewsArticle_print&ID=2302681.
Invuity Press Release, Jun. 13, 2017, “Invuity Provides Update on Photonblade Commercialization”, pp. 1-2.
Invuity Press Release, Jul. 25, 2017, “Invuity Reports 2017 Second Quarter, Six-Month Financial Results”, pp. 1-2.
Product Brochure, Invuity PhotonBlade, downloaded from ttp://invuity.com/products/photonblade on Jun. 19, 2017.
MAUDE Adverse Event Report; Invuity, Inc. Photonblade, FDA, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi_id=6679528& pc=GEI, Event Date: Jun. 9, 2017.
MAUDE Adverse Event Report; Invuity, Inc. Photonblade, FDA, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi id=6679521&pc=GEI, Event Date: Jun. 5, 2017.
MAUDE Adverse Event Report; Invuity, Inc. Photonblade, FDA, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi_id=6679511&pc=GEI, Event Date: Jun. 2, 2017.
MAUDE Adverse Event Report; Invuity, Inc. Photonblade, FDA, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi_id=6679508&pc=GEI 2, Event Date: May 23, 2017.
US Securities and Exchange Commission, EDGAR database, Form 10Q, Signed Jul. 26, 2017, https://www.sec.gov/Archives/edgar/data/1393020/000155837017005346/ivty-20170630x10q.htm.
US Securities and Exchange Commission, EDGAR database, Form 10Q, Signed Nov. 7, 2017, https://www.sec.gov/Archives/edgar/data/1393020/000155837017008398/ivty-20170930x10q.htm.
Related Publications (1)
Number Date Country
20230263567 A1 Aug 2023 US
Provisional Applications (1)
Number Date Country
62531188 Jul 2017 US
Divisions (1)
Number Date Country
Parent 16232705 Dec 2018 US
Child 17028192 US
Continuations (2)
Number Date Country
Parent 17028192 Sep 2020 US
Child 18140777 US
Parent 15887503 Feb 2018 US
Child 16232705 US